NANA BERIKASHVILI: Open Payments
NPI 1831129600 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 12 payments from 7 companies in 2025. Trend: 2023 $328 · 2024 $351 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $233 |
| Neurocrine BioSciences, Inc. | 1 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Vanda Pharmaceuticals Inc. | 1 | $112 |
| Axsome Therapeutics, Inc. | 1 | $84 |
| Alkermes, Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: COBENFY, INGREZZA, CAPLYTA, FANAPT, Auvelity, LYBALVI, Qelbree.
Industry payments across DE — which companies pay providers there.
